newsfilter
← Latest News
Business Wire·

Ipsen Delivers Strong Sales Growth for the First Nine Months and Improves Its Full-Year Guidance

Regulatory News: Ipsen ((Euronext: IPN, OTC:IPSEY), a global specialty-driven biopharmaceutical group, publishes its sales performance for the third quarter of 2021 and the year to date. Sales summary(unaudited IFRS consolidated sales)